Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001193125-26-343067

Director acquired 400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kunz Barbara Lopez Director 2026-08-06 Option exercise +400 400 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kunz Barbara Lopez Director 2026-08-06 Option exercise · Restricted Stock Unit −400 0 D: show line 2 in the form
Loading xslF345X06/ownership.xml…